drugset / Trial / NCT04673396
Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor
Non-randomizedSequentialOpen-labelTreatment
Summary
This study was designed as a single-center, open, non-randomized trial.
Timeline
- Start
- 2020-09-22
- Primary completion
- 2021-12-31
- Completion
- 2022-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Norcantharidin | Small molecule | — | Other |
| Comparator | Sodium Demethylcantharidate | Unknown | 20 mg | Other |